These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 37026255)

  • 1. Intricate insights into immune response in dry eye disease.
    Kaur RP; Gurnani B; Kaur K
    Indian J Ophthalmol; 2023 Apr; 71(4):1248-1255. PubMed ID: 37026255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.
    Sheppard J; Shen Lee B; Periman LM
    Ann Med; 2023 Dec; 55(1):241-252. PubMed ID: 36576348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options.
    Periman LM; Perez VL; Saban DR; Lin MC; Neri P
    J Ocul Pharmacol Ther; 2020 Apr; 36(3):137-146. PubMed ID: 32175799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dry Eye Disease: Early Recognition with Guidance on Management and Treatment for Primary Care Family Physicians.
    Verjee MA; Brissette AR; Starr CE
    Ophthalmol Ther; 2020 Dec; 9(4):877-888. PubMed ID: 33090327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rethinking dry eye disease: a perspective on clinical implications.
    Bron AJ; Tomlinson A; Foulks GN; Pepose JS; Baudouin C; Geerling G; Nichols KK; Lemp MA
    Ocul Surf; 2014 Apr; 12(2 Suppl):S1-31. PubMed ID: 24725379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Molecular Mechanisms Responsible for Tear Hyperosmolarity-Induced Pathological Changes in the Eyes of Dry Eye Disease Patients.
    Harrell CR; Feulner L; Djonov V; Pavlovic D; Volarevic V
    Cells; 2023 Dec; 12(23):. PubMed ID: 38067183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management Strategies for Evaporative Dry Eye Disease and Future Perspective.
    Rolando M; Merayo-Lloves J
    Curr Eye Res; 2022 Jun; 47(6):813-823. PubMed ID: 35521685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
    McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
    BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining Dry Eye from a Clinical Perspective.
    Tsubota K; Pflugfelder SC; Liu Z; Baudouin C; Kim HM; Messmer EM; Kruse F; Liang L; Carreno-Galeano JT; Rolando M; Yokoi N; Kinoshita S; Dana R
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Video display terminal use and dry eye: preventive measures and future perspectives.
    Kamøy B; Magno M; Nøland ST; Moe MC; Petrovski G; Vehof J; Utheim TP
    Acta Ophthalmol; 2022 Nov; 100(7):723-739. PubMed ID: 35122403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Inflammatories in the Treatment of Dry Eye Disease: A Review.
    Perez VL; Mah FS; Willcox M; Pflugfelder S
    J Ocul Pharmacol Ther; 2023 Mar; 39(2):89-101. PubMed ID: 36796014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Dry Eye Symptoms: Current Trends and Issues of Dry Eye Questionnaires in Japan.
    Shiraishi A; Sakane Y
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES23-DES28. PubMed ID: 30481802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition and Diagnostic Criteria of Dry Eye Disease: Historical Overview and Future Directions.
    Shimazaki J
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES7-DES12. PubMed ID: 30481800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aqueous-deficient dry eye disease: Preferred practice pattern guidelines on clinical approach, diagnosis, and management.
    Donthineni PR; Doctor MB; Shanbhag S; Kate A; Galor A; Djalilian AR; Singh S; Basu S
    Indian J Ophthalmol; 2023 Apr; 71(4):1332-1347. PubMed ID: 37026265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification.
    Barabino S; Benitez-Del-Castillo JM; Fuchsluger T; Labetoulle M; Malachkova N; Meloni M; Utheim TP; Rolando M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8642-8652. PubMed ID: 32964952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic benefits of blinking exercises in dry eye disease.
    Kim AD; Muntz A; Lee J; Wang MTM; Craig JP
    Cont Lens Anterior Eye; 2021 Jun; 44(3):101329. PubMed ID: 32409236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface.
    Jeyabalan N; Pillai AM; Khamar P; Shetty R; Mohan RR; Ghosh A
    Indian J Ophthalmol; 2023 Apr; 71(4):1285-1291. PubMed ID: 37026260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study.
    Yu K; Bunya V; Maguire M; Asbell P; Ying GS;
    Ophthalmology; 2021 Oct; 128(10):1384-1392. PubMed ID: 33785415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular Pharmacology of Tear Film, Dry Eye, and Allergic Conjunctivitis.
    Gulati S; Jain S
    Handb Exp Pharmacol; 2017; 242():97-118. PubMed ID: 27913889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated Tear Fluid Nociception-Associated Factors, Corneal Dendritic Cell Density, and Vitamin D Levels in Evaporative Dry Eye.
    Khamar P; Nair AP; Shetty R; Vaidya T; Subramani M; Ponnalagu M; Dhamodaran K; D'souza S; Ghosh A; Pahuja N; Deshmukh R; Ahuja P; Sainani K; Nuijts RMMA; Das D; Ghosh A; Sethu S
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2532-2542. PubMed ID: 31195410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.